Laboratorio de análisis Echevarne

Clinical Intestinal Microbiome

Clinical Intestinal Microbiome

Analysis of the bacterial microbiota present in the intestine by means of a stool sample to determine if there is a dysbiosis, or imbalance in the microbiota.

A dysbiosis can mean that certain metabolic functions do not take place or that an opportunistic pathogen proliferates as there is no other bacterium to prevent it.

Which patients is it most useful for?

Patients with obesity and/or metabolic diseases: Diabetes Mellitus 2, dyslipidaemia, hypertension, non-alcoholic steatohepatitis (NASH), etc.
Patients with gastrointestinal pathologies: gastrointestinal infections, diarrhoea due to the use of antibiotics, inflammatory bowel disease, irritable bowel syndrome, colon cancer, etc.
Patients with autism, depression and anxiety.
  • 380€
  • Sample:
    Stools
  • Volume:
    Specific sample collection kit
    (Request from Laboratory)
  • Storage of sample:
    4oC
  • Turnaround time:
    30 working days
    (May vary)

Benefits

Every human has their own unique microbiome, which could be compared to a fingerprint. The aim is to find out what it is like and correct it if there is an imbalance with the diet.

This study is considered to be a very useful tool to help correct imbalances in the gut microbiota through diet, nutritional supplements and/or pharmaceutical products.

What does it analyse?

The analysis determines all the bacterial genera found in the individual’s digestive microbiome by ultrasequencing 16S rRNA (16S ribosomal RNA). It is then compared with the other healthy microbiomes sequenced to date using a comparative bioinformatic analysis.

The most relevant bacterial species and their effect are reported.

Other Main Analysis

Consult your results